Ramesh Juneja’s net worth over time
Only dates with a published estimate are shown. Nothing is filled in between. Tap or hover a bar to see the source.
See the numbers as a table
| Date | Estimate | Source |
| 2022 | $1.4 billion | Forbes World's Billionaires List 2022 |
| 2023 | $1.5 billion | Forbes World's Billionaires List 2023 |
| 2024 | $3 billion | Forbes World's Billionaires List 2024 |
| 2025 | $3.1 billion | Forbes World's Billionaires List 2025 |
| 2026 | $2.9 billion | Forbes World's Billionaires List 2026 |
| Oct 2026 | $2.8 billion | Forbes Real-Time Billionaires · Forbes real-time estimate |
Where the money comes from
These are the main sources of wealth named in the reporting we cite. No published source breaks the total into exact amounts, so we do not show percentages.
Ramesh Juneja’s fortune in real-life terms
Based on the Forbes Real-Time Billionaires estimate above. Median full-time U.S. pay is $65,416 a year ($1,258 a week, BLS, Q2 2026), before taxes. Typical (median) U.S. family net worth is $216,100 (Federal Reserve, 2025 Survey of Consumer Finances).
How do you compare to Ramesh Juneja? New
Type your yearly income and see how you stack up. It runs in your browser: nothing you type is saved or sent anywhere.
Ramesh Juneja has an estimated net worth of $2.8 billion, according to Forbes Real-Time Billionaires, Ramesh Juneja profile (figures as of October 20, 2026). That is up from $1.4 billion in 2022.
Ramesh Juneja is an Indian businessman in pharmaceuticals and the chairman of Mankind Pharma. He started out in the drug business in 1974 as a medical representative at KeePharma Ltd. In 1975, he moved to Lupin Limited and worked there as a first line manager for almost 8 years. After leaving Lupin in 1983, he began building businesses of his own. Forbes tracked his wealth at $2.8 billion in October 2026.
His biggest business move came in 1995, when he cofounded Mankind Pharma with his younger brother Rajeev Juneja. The company began with ₹50 lakhs and 25 medical representatives. Mankind Pharma sells generic drugs, including antibiotics and treatments for cardiovascular diseases, in over two dozen markets worldwide. It also makes well-known condom and pregnancy test kit brands. In May 2023, the company went public in India and raised 43.3 billion rupees ($529 million).
How Ramesh Juneja built his wealth
Juneja made his money by building Mankind Pharma into a large drug company. Before that, he learned the business through sales and management roles at KeePharma Ltd. and Lupin Limited. He also started Bestochem in 1983 before exiting in 1994. That long path gave him industry experience before launching Mankind Pharma in 1995, a self-made business that became the center of his fortune in healthcare.
Mankind Pharma earns revenue from a mix of products. Its generic medicines include antibiotics and treatments for cardiovascular diseases, and it sells them in over two dozen markets worldwide. The company also makes consumer health products such as condoms and pregnancy test kits. Another part of its growth came from international expansion, including the U.S., led by his son Arjun, who serves as chief operating officer.
Forbes net worth updates
Forbes valued Juneja at $1.4 billion in 2022, then $1.5 billion in 2023. In May 2023, Mankind Pharma went public in India and raised 43.3 billion rupees ($529 million). That public listing was a major money event for the family business. It also put more focus on the company’s scale, from generic medicines to consumer brands, and on its reach across global markets.
After the listing, the Forbes estimate rose to $3 billion in 2024 and $3.1 billion in 2025, before moving to $2.9 billion in 2026. As of October 20, 2026, Forbes' real-time billionaires tracker showed $2.8 billion. Across those years, his fortune stayed tied to Mankind Pharma, the company he cofounded in 1995 and later brought to the public market in 2023.
Career and money timeline
- 1974
He started in pharmaceuticals at KeePharma Ltd. as a medical representative.
- 1975
He joined Lupin Limited and worked there for almost 8 years.
- 1983
He left Lupin and started Bestochem in partnership.
- 1994
He withdrew his ownership from Bestochem.
- 1995
He cofounded Mankind Pharma with Rajeev Juneja.
- 2023
Mankind Pharma went public in India and raised 43.3 billion rupees.
Ramesh Juneja net worth FAQ
What is Ramesh Juneja's net worth?
Ramesh Juneja's net worth is an estimated $2.8 billion, according to Forbes Real-Time Billionaires, Ramesh Juneja profile (October 20, 2026). It is an estimate, not an official figure.
How did Ramesh Juneja get so rich?
The main sources named in the reporting we cite are: Pharmaceuticals.
Is Ramesh Juneja a billionaire?
Yes. Forbes Real-Time Billionaires estimates Ramesh Juneja is worth $2.8 billion.
How has Ramesh Juneja's net worth changed?
The earliest published estimate we track is $1.4 billion (2022, Forbes World's Billionaires List 2022). The latest is $2.8 billion (October 20, 2026).
What company is Ramesh Juneja best known for?
He is best known for Mankind Pharma, the drug company he cofounded in 1995 with his younger brother Rajeev Juneja. He is the chairman.
What products helped build his fortune?
His wealth is tied to Mankind Pharma’s mix of generic medicines and consumer health products. The company sells antibiotics, cardiovascular treatments, condoms, and pregnancy test kits.
Sources
- Forbes Real-Time Billionaires, Ramesh Juneja profile (October 20, 2026)
- Forbes World's Billionaires List 2022, Ramesh Juneja profile (April 5, 2022)
- Forbes World's Billionaires List 2023, Ramesh Juneja profile (April 4, 2023)
- Forbes World's Billionaires List 2024, Ramesh Juneja profile (April 2, 2024)
- Forbes World's Billionaires List 2025, Ramesh Juneja profile (April 2025)
- Forbes World's Billionaires List 2026, Ramesh Juneja profile (March 10, 2026)
- U.S. Bureau of Labor Statistics, Usual Weekly Earnings (Q2 2026) (July 2026)
- Federal Reserve, 2025 Survey of Consumer Finances (median family net worth, Table 4) (October 2026)
- Background facts: Wikipedia, Ramesh Juneja (accessed October 23, 2026). Used for career facts only, never for figures.
Photo: Payal 2013, CC BY-SA 3.0, via Wikimedia Commons.
Every number on this page is an estimate published by the source named next to it. We never fill in years with our own guesses. How we handle estimates.